A detailed history of Northern Trust Corp transactions in Axonics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 458,281 shares of AXNX stock, worth $32.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
458,281
Previous 454,353 0.86%
Holding current value
$32.5 Million
Previous $30.5 Million 4.52%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$67.3 - $69.67 $264,354 - $273,663
3,928 Added 0.86%
458,281 $31.9 Million
Q2 2024

Aug 14, 2024

SELL
$66.47 - $69.65 $1.36 Million - $1.42 Million
-20,431 Reduced 4.3%
454,353 $30.5 Million
Q1 2024

May 14, 2024

SELL
$56.67 - $69.36 $9.47 Million - $11.6 Million
-167,045 Reduced 26.03%
474,784 $32.7 Million
Q4 2023

Feb 13, 2024

BUY
$49.38 - $63.75 $1.51 Million - $1.96 Million
30,680 Added 5.02%
641,829 $39.9 Million
Q3 2023

Nov 13, 2023

SELL
$48.64 - $62.51 $2.22 Million - $2.85 Million
-45,578 Reduced 6.94%
611,149 $34.3 Million
Q2 2023

Aug 11, 2023

BUY
$47.99 - $60.21 $489,018 - $613,539
10,190 Added 1.58%
656,727 $33.1 Million
Q1 2023

May 15, 2023

SELL
$52.6 - $67.34 $218,447 - $279,663
-4,153 Reduced 0.64%
646,537 $35.3 Million
Q4 2022

Feb 13, 2023

BUY
$59.56 - $76.6 $165,695 - $213,101
2,782 Added 0.43%
650,690 $40.7 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $524,827 - $707,376
9,055 Added 1.42%
647,908 $45.6 Million
Q2 2022

Aug 12, 2022

SELL
$39.5 - $64.42 $532,578 - $868,574
-13,483 Reduced 2.07%
638,853 $36.2 Million
Q1 2022

May 13, 2022

BUY
$43.74 - $62.76 $3.1 Million - $4.45 Million
70,875 Added 12.19%
652,336 $40.8 Million
Q4 2021

Feb 08, 2022

BUY
$50.01 - $73.35 $5.05 Million - $7.41 Million
101,027 Added 21.03%
581,461 $32.6 Million
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $2.5 Million - $3.32 Million
42,192 Added 9.63%
480,434 $31.3 Million
Q2 2021

Aug 13, 2021

BUY
$51.39 - $66.9 $4.24 Million - $5.52 Million
82,458 Added 23.18%
438,242 $27.8 Million
Q1 2021

May 12, 2021

SELL
$49.14 - $59.89 $1.11 Million - $1.35 Million
-22,606 Reduced 5.97%
355,784 $21.3 Million
Q4 2020

Feb 11, 2021

SELL
$42.19 - $51.5 $1.15 Million - $1.4 Million
-27,165 Reduced 6.7%
378,390 $18.9 Million
Q3 2020

Nov 16, 2020

BUY
$35.33 - $51.04 $360,330 - $520,556
10,199 Added 2.58%
405,555 $20.7 Million
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $3.78 Million - $6.58 Million
165,158 Added 71.75%
395,356 $13.9 Million
Q1 2020

May 14, 2020

BUY
$16.44 - $37.73 $461,306 - $1.06 Million
28,060 Added 13.88%
230,198 $5.85 Million
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $281,905 - $417,168
14,405 Added 7.67%
202,138 $5.6 Million
Q3 2019

Nov 13, 2019

BUY
$26.92 - $42.41 $2.24 Million - $3.53 Million
83,126 Added 79.47%
187,733 $5.05 Million
Q2 2019

Aug 13, 2019

BUY
$18.54 - $40.97 $434,985 - $961,238
23,462 Added 28.91%
104,607 $4.29 Million
Q1 2019

May 13, 2019

SELL
$13.32 - $24.35 $11,188 - $20,454
-840 Reduced 1.02%
81,145 $1.94 Million
Q4 2018

Feb 12, 2019

BUY
$13.2 - $16.43 $1.08 Million - $1.35 Million
81,985 New
81,985 $1.24 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.